Total raised
—
Stage
Pre-Funding
Founded
2020
Headcount
4
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences
About
Innohale Therapeutics develops inhaled nitric oxide (iNO) delivery solutions for the treatment of respiratory conditions from many etiologies (including COVID-19) and severe lung infections. The technology produces iNO from ambient air, which improves treatment accuracy and reduces costs and logistics burden.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Innohale Therapeutics' primary focus?
- Innohale Therapeutics develops inhaled nitric oxide (iNO) delivery solutions for respiratory conditions, including those from COVID-19 and severe lung infections.
- What is the core technology behind Innohale Therapeutics' solutions?
- Innohale Therapeutics' technology produces inhaled nitric oxide (iNO) from ambient air, aiming to improve treatment accuracy and reduce costs and logistical burdens.
- When was Innohale Therapeutics founded?
- Innohale Therapeutics was founded in April 2020.
- Where is Innohale Therapeutics headquartered?
- Innohale Therapeutics is headquartered in Tel Aviv-Yafo, Israel.
- What is Innohale Therapeutics' current funding stage?
- Innohale Therapeutics is currently in the Pre-Funding stage.
- How many employees does Innohale Therapeutics have?
- Innohale Therapeutics has 4 employees.
- Who are the founders of Innohale Therapeutics?
- The founders of Innohale Therapeutics are Dan Rappaport and Yaacov Nitzan.
- What industry sector does Innohale Therapeutics operate in?
- Innohale Therapeutics operates primarily in the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Life Support.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesLife Support
Target customers
Healthcare & Life SciencesHealthcareProvidersMedical Devices IndustryMedical Equipment
Business model
B2B
Tags
cardiovascularrespiratorydeliverytherapeutics